The Quality of Recovery After Intrathecal Morphine or Adductor Canal Block in Anterior Cruciate Ligament Reconstruction
Launched by CUKUROVA UNIVERSITY · Feb 14, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different pain management techniques—intrathecal morphine (ITM) and adductor canal block (ACB)—to see which one helps patients recover better after having knee surgery to repair a torn anterior cruciate ligament (ACL). The researchers want to understand how these methods can improve the quality of recovery, which refers to how well patients feel and function after surgery. They will use a questionnaire called the Quality of Recovery 40 (QoR-40) to measure various aspects of recovery, such as pain levels and overall satisfaction.
To be eligible for this study, participants should be adults aged 18 to 65 who are in good health (classified as ASA physical status I or II) and scheduled for elective ACL reconstruction surgery. Unfortunately, those with certain medical conditions, such as bleeding disorders or severe obesity, will not be included. If you participate, you can expect to receive either ITM or ACB as part of your spinal anesthesia during surgery, and your recovery will be monitored closely to see how effective these methods are in managing pain and speeding up your recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anesthesiologists (ASA) physical status I or II adult patients aged 18-65 years undergoing elective arthroscopic anterior cruciate ligament reconstruction will be included in the study.
- Exclusion Criteria:
- • We will exclude patients with known coagulopathy, allergies to the studied drugs, obesity (BMI \>35kg/m2), renal and/or hepatic insufficiency, chronic pain syndrome, mental impairment, depression, chronic alcoholism, and usage of antidepressant and analgesic drugs before surgery.
About Cukurova University
Cukurova University, a prominent institution located in Adana, Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic research environment that promotes the development of new therapies and treatment modalities. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of scientific rigor. Cukurova University aims to contribute significantly to the global medical community by facilitating groundbreaking studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Adana, Sariçam, Turkey
Adana, Saricam, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials